-
Akwụkwọ akụkọ Iwu ọhụrụ
1. A ga-amachibido iwu ndebanye aha FDA ọhụrụ maka ịchọ mma ịchọ mma US na-enweghị ndebanye aha FDA n'ịre ahịa. Dị ka iwu Modernization of Cosmetics Regulation Act nke 2022, nke Onye isi ala Biden bịanyere aka na ya na Disemba 29, 2022, ihe ịchọ mma niile ebupụ na United States ga-abụrịrị FDA-edeba aha...GỤKWUO -
Ọkwa Ememme Mmiri
Biko mee ka amara na a ga-emechi ụlọ ọrụ anyị site na Feb. 4 ruo Feb.18 n'ihi Ememe Mmiri. A ga-anabata iwu ọ bụla mana agaghị ahazi ya ruo Feb.19, ụbọchị azụmaahịa mbụ mgbe Ememme Mmiri gasịrị. Ndo maka nsogbu ọ bụla kpatara.GỤKWUO -
2023 API 88th CHINA
Ozi gbasara JYMed na 2023 API CHINA 【on-saịtị】 N'okpuru nduzi nke Vice General Manager Zhi Qin, Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọkarị JYMed) sonyere na ihe ngosi a dị ebube. JYMed gosipụtara ngwaahịa bara uru Semaglutide, Liraglutide, Tirzepatide, O ...GỤKWUO -
Nabata izute anyị na ihe ngosi API na ngwaahịa Qindao China JYMed: N4K32
GỤKWUO -
JYMed jikọtara gị na PCHi
Mgbe afọ abụọ nke atụmanya, 2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) ka emere na Guangzhou Canton Fair Complex na February 15-17, 2023. PCHi bụ ihe ngosi ahia ahia mba ofesi na-eje ozi ihe ịchọ mma zuru ụwa ọnụ, kwa ...GỤKWUO -
Semeglutide API nke Shenzhen JYMed nabatara nke mbụ ogbe nke anụ ụlọ NMPA na debara aha na US FDA (DMF No. 036009) na ọnọdụ "A".
Na Mee 2022, Shenzhen JYMed Technology Co., Ltd. (nke a na-akpọ JYMed peptide) nyefere ngwa maka ndebanye aha nke semaglutide API na US Food and Drug Administration (FDA) (nọmba ndebanye aha DMF: 036009), Ọ gafere nyocha iguzosi ike n'ezi ihe, na ọnọdụ ugbu a i...GỤKWUO -
Peptides ọla kọpa: Uru nlekọta anụ ahụ na ntutu na otu esi eji ha
Anyị na-agụnye ngwaahịa ndị anyị chere na ndị na-agụ anyị ga-ahụ na ọ bara uru. Anyị nwere ike nweta obere ọrụ ma ọ bụrụ na ịzụrụ ihe site na njikọ dị na ibe a. Nke a bụ usoro anyị. Peptides bụ amino asịd na-eme n'ezie nke na-enyere aka ịmepụta collagen na elastin, anụ ahụ njikọ abụọ na-ahụ maka s ...GỤKWUO -
Ozempic (Semaglutide) ịgba ọgwụ: ojiji, mmetụta akụkụ, usoro onunu ogwu
Erica Prouty, PharmD, bụ ọkachamara n'ịzụ ọgwụ na-enyere ndị ọrịa aka na ọgwụ na ụlọ ahịa ọgwụ na North Adams, Massachusetts. N'ime ọmụmụ anụmanụ na-abụghị nke mmadụ, egosiri semaglutide na-akpata ụbụrụ thyroid C-cell na òké. Agbanyeghị, amabeghị ma ihe egwu a gbasara mmadụ….GỤKWUO -
Mwepu nke acid fatty na nchọpụta nke peptide na ọgwụ protein
Daalụ maka ileta Nature.com. Ụdị ihe nchọgharị ị na-eji nwere nkwado CSS nwere oke. Maka ahụmịhe kachasị mma, anyị na-akwado ka ị jiri ihe nchọgharị emelitere (ma ọ bụ gbanyụọ ọnọdụ ndakọrịta na Internet Explorer). Ka ọ dị ugbu a, iji hụ na nkwado na-aga n'ihu, anyị ga-enye saịtị ahụ na-enweghị s ...GỤKWUO -
Klas I ọhụrụ ọgwụ JYMed enweela ọganihu dị ukwuu, a na-atụ anya na Laipushutai ga-abụ ahịrị mbụ nke ọgwụ UC.
Na June 29, 2017, mmepe nke Laipushutai, klas m nkà mmụta ọgwụ ọhụrụ na nkwado nkwado nke JYMed na Guangzhou Linkhealth Medical Technology Co., Ltd., emeela ọganihu dị ukwuu. CFDA anabatala nkwupụta IND ọgwụ ahụ. JYMed na Guangzhou Lin…GỤKWUO -
Akụkọ & Ihe Omume Ngalaba Ngwaahịa Peptide dị na JYMed agafeela nyocha saịtị n'enweghị ntụpọ sitere na FDA.
Jiri obi ụtọ kelee ngalaba ngwaahịa ngwaahịa Polypeptide anyị maka ịgafe nyocha US FDA na saịtị na "nrụmahụ efu"! Ịgafe FDA na saịtị na "nrụrụ efu" bụ nnukwu ihe omume na akụkọ mmepe cGMP anyị. Ọ bụghị naanị na ọ pụtara na API anyị nwere obt...GỤKWUO
